Proteolysis targeting chimera technology: a novel strategy for treating diseases of the central nervous systemOACSCDCSTPCD
Proteolysis targeting chimera technology: a novel strategy for treating diseases of the central nervous system
Ke Ma;Xiao-Xiao Han;Xiao-Ming Yang;Song-Lin Zhou
College of Life Science,Nantong University,Nantong,Jiangsu Province,ChinaKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education,Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair,Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,ChinaKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education,Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair,Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,ChinaKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education,Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair,Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,China
Alzheimer's diseasedisease treatmentdrug developmentHuntington's diseaseproteolysis targeting chimerastroketargeted degradation
Alzheimer's diseasedisease treatmentdrug developmentHuntington's diseaseproteolysis targeting chimerastroketargeted degradation
《中国神经再生研究（英文版）》 2021 (10)
1944-1949,6
This work was supported by the National Natural Science Foundation of China, No. 81870975 (to SLZ)and the Nantong Science and Technology Innovation Program, China, No. JC2019028 (to XMY).